SCHEMBL14720727

SCHEMBL14720727

OC1(Cc2ccc(C=C3CCN(C4CCC4)CC3)cn2)CCOCC1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 14/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720772 0.85 HRH3 (0.37) HRH3
SCHEMBL14720504 0.82 HRH3 (0.35) HRH3
SCHEMBL14720505 0.82 HRH3 (0.35) HRH3
SCHEMBL14720667 0.79 SRD5A2 (0.34) HRH3
SCHEMBL14720746 0.77 HRH3 (0.38) HRH3
SCHEMBL14720924 0.75 SRD5A2 (0.38) HRH3
SCHEMBL14720798 0.74 SRD5A2 (0.32)
SCHEMBL14720847 0.74 HRH3 (0.38) HRH3
SCHEMBL14720966 0.74 HRH3 (0.36) HRH3
SCHEMBL14720612 0.74 HRH3 (0.35) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed